Rafael Cardoso1, Anna Zhu, Feng Guo, Thomas Heisser, Michael Hoffmeister, Hermann Brenner. 1. Division of Preventive Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg; Faculty of Medicine Heidelberg, University of Heidelberg; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg; German Cancer Consortium, German Cancer Research Center, Heidelberg.
Abstract
BACKGROUND: The use of colonoscopy has increased and colorectal cancer (CRC) incidence has decreased after the introduction of screening colonoscopy in Germany. However, it remains unknown to what extent progress has been achieved in the prevention of cancer in the proximal colon, distal colon, and rectum. METHODS: We analyzed trends in CRC incidence (2000-2016) and mortality (2000-2018) in Germany by sex, age, and tumor location. RESULTS: The age-standardized incidence of CRC declined by 22.4% (from 65.3 to 50.7 per 100 000) in men and by 25.5% (from 42.7 to 31.8 per 100 000) in women. CRC mortality declined by 35.8% (from 29.6 to 19.0 per 100 000) in men and by 40.5% (19.0 to 11.3 per 100 000) in women. Despite demographic changes, the annual numbers of CRC cases and deaths still decreased from about 60 400 to 58 300 and from around 28 700 to 24 200, respectively. The decline in incidence was greatest in groups aged ≥ 55 years. While the incidence of cancer in the distal colon and rectum decreased by 34.5% and 26.2%, respectively, in men and by 41.0% and 27.9% in women, the incidence of proximal colon cancer remained stable in men and decreased by only 7.0% in women. However, a major shift towards earlier stages was observed for the proximal cancers. CONCLUSION: The results support the assumption that the increased use of colo - noscopy has contributed to substantial reductions in the incidence of distal CRC incidence and the mortality from cancers in the entire colon and rectum.
BACKGROUND: The use of colonoscopy has increased and colorectal cancer (CRC) incidence has decreased after the introduction of screening colonoscopy in Germany. However, it remains unknown to what extent progress has been achieved in the prevention of cancer in the proximal colon, distal colon, and rectum. METHODS: We analyzed trends in CRC incidence (2000-2016) and mortality (2000-2018) in Germany by sex, age, and tumor location. RESULTS: The age-standardized incidence of CRC declined by 22.4% (from 65.3 to 50.7 per 100 000) in men and by 25.5% (from 42.7 to 31.8 per 100 000) in women. CRC mortality declined by 35.8% (from 29.6 to 19.0 per 100 000) in men and by 40.5% (19.0 to 11.3 per 100 000) in women. Despite demographic changes, the annual numbers of CRC cases and deaths still decreased from about 60 400 to 58 300 and from around 28 700 to 24 200, respectively. The decline in incidence was greatest in groups aged ≥ 55 years. While the incidence of cancer in the distal colon and rectum decreased by 34.5% and 26.2%, respectively, in men and by 41.0% and 27.9% in women, the incidence of proximal colon cancer remained stable in men and decreased by only 7.0% in women. However, a major shift towards earlier stages was observed for the proximal cancers. CONCLUSION: The results support the assumption that the increased use of colo - noscopy has contributed to substantial reductions in the incidence of distal CRC incidence and the mortality from cancers in the entire colon and rectum.
Authors: Evelien Dekker; Pieter J Tanis; Jasper L A Vleugels; Pashtoon M Kasi; Michael B Wallace Journal: Lancet Date: 2019-10-19 Impact factor: 79.321
Authors: Hendrik Bläker; Bert Hildebrandt; Hanno Riess; Moritz von Winterfeld; Barbara Ingold-Heppner; Wilfried Roth; Matthias Kloor; Peter Schirmacher; Manfred Dietel; Sha Tao; Lina Jansen; Jenny Chang-Claude; Alexis Ulrich; Hermann Brenner; Michael Hoffmeister Journal: Int J Cancer Date: 2014-09-24 Impact factor: 7.396
Authors: Michael K Dougherty; Alison T Brenner; Seth D Crockett; Shivani Gupta; Stephanie B Wheeler; Manny Coker-Schwimmer; Laura Cubillos; Teri Malo; Daniel S Reuland Journal: JAMA Intern Med Date: 2018-12-01 Impact factor: 21.873
Authors: Enrique Quintero; Antoni Castells; Luis Bujanda; Joaquín Cubiella; Dolores Salas; Ángel Lanas; Montserrat Andreu; Fernando Carballo; Juan Diego Morillas; Cristina Hernández; Rodrigo Jover; Isabel Montalvo; Juan Arenas; Eva Laredo; Vicent Hernández; Felipe Iglesias; Estela Cid; Raquel Zubizarreta; Teresa Sala; Marta Ponce; Mercedes Andrés; Gloria Teruel; Antonio Peris; María-Pilar Roncales; Mónica Polo-Tomás; Xavier Bessa; Olga Ferrer-Armengou; Jaume Grau; Anna Serradesanferm; Akiko Ono; José Cruzado; Francisco Pérez-Riquelme; Inmaculada Alonso-Abreu; Mariola de la Vega-Prieto; Juana Maria Reyes-Melian; Guillermo Cacho; José Díaz-Tasende; Alberto Herreros-de-Tejada; Carmen Poves; Cecilio Santander; Andrés González-Navarro Journal: N Engl J Med Date: 2012-02-23 Impact factor: 91.245
Authors: Yin Cao; Reiko Nishihara; Kana Wu; Molin Wang; Shuji Ogino; Walter C Willett; Donna Spiegelman; Charles S Fuchs; Edward L Giovannucci; Andrew T Chan Journal: JAMA Oncol Date: 2016-06-01 Impact factor: 31.777
Authors: Theodore R Levin; Douglas A Corley; Christopher D Jensen; Joanne E Schottinger; Virginia P Quinn; Ann G Zauber; Jeffrey K Lee; Wei K Zhao; Natalia Udaltsova; Nirupa R Ghai; Alexander T Lee; Charles P Quesenberry; Bruce H Fireman; Chyke A Doubeni Journal: Gastroenterology Date: 2018-07-19 Impact factor: 22.682
Authors: Hermann Brenner; Michael Hoffmeister; Thomas Heisser; Anna Zhu; Rafael Cardoso Journal: Dtsch Arztebl Int Date: 2021-10-01 Impact factor: 5.594
Authors: Thomas Heisser; Tobias Möllers; Rafael Cardoso; Tobias Niedermaier; Michael Hoffmeister; Hermann Brenner Journal: Dtsch Arztebl Int Date: 2021-10-15 Impact factor: 5.594
Authors: Thomas Heisser; Andreas Simon; Jana Hapfelmeier; Michael Hoffmeister; Hermann Brenner Journal: Cancers (Basel) Date: 2022-08-08 Impact factor: 6.575